SLC6A14 was also proposed to take over the defective OCTN2 and to mediate transport of butyryl-L carnitine, a compound used for treatment of ulcerative colitis (Srinivas et al., 2007). The gene discussed is SLC6A14; the disease is ulcerative colitis.